Prostate cancer is the most common cancer among men, and it's the second leading cause of cancer death for men in the U.S.

Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.

“As a two-time prostate cancer survivor, I enjoy today as if it will be my last,” Jesse said. “I engage every man I meet ...

Screening for prostate cancer becomes more complex in men over the age of 70. The US Preventive Services Task Force (USPSTF) currently recommends against routine PSA testing in this age group. The PSA ...

BALTIMORE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), and the Prostate Cancer Foundation (PCF) today ...

Prostate cancer often earns the label “silent killer” because it can develop and progress for years without producing noticeable symptoms. Understanding this timeline becomes crucial for men seeking ...

SCREENING men for prostate cancer could slash deaths by 13 per cent, saving thousands of lives a year, a study suggests. Results of the long-term European trial – one of the largest in ...

Prostate-specific antigen screening resulted in 13% lower prostate cancer mortality over a median 23 years of follow-up.